SEC Comment Letter 0000000000-24-001704 to CURIS INC (CRIS)
CURIS INC
Date: Feb. 13, 2024 · CIK: 0001108205 · Accession: 0000000000-24-001704
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276950
Letter
United States securities and exchange commission logo February 13, 2024 Diantha Duvall Chief Financial Officer Curis Inc. 128 Spring Street, Building C – Suite 500 Lexington, MA 02421 Re:Curis Inc. Registration Statement on Form S-3 Filed February 8, 2024 File No. 333-276950 Dear Diantha Duvall: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Cynthia Mazareas
Show Raw Text
United States securities and exchange commission logo
February 13, 2024
Diantha Duvall
Chief Financial Officer
Curis Inc.
128 Spring Street, Building C – Suite 500
Lexington, MA 02421
Re:Curis Inc.
Registration Statement on Form S-3
Filed February 8, 2024
File No. 333-276950
Dear Diantha Duvall:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Cynthia Mazareas